AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pluri Inc. Director's Dealing 2022

Feb 14, 2022

6990_rns_2022-02-14_9a7a71b6-fd20-410b-88a3-2bcb93baad48.htm

Director's Dealing

Opens in your device viewer

_________ false


��	2 381
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001	12448
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	14/02/2022
	www.isa.gov.il			www.tase.co.il				Reference:	2022-02-018382	Time of broadcast: 23:39 23:39

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.


Attached hereto is a report on	�� "�/�.�� -Zami Aberman -Form 4

ea155622-4aberman_pluristemtherapeuticsincAsFiled_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 30/12/2021
Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected] Company site: www.pluristem.com

Previous names of reporting entity:

Name of the Signatory: Franco Yehuda Chen Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company:
Address: Gogen 17 , Kiryat Ata 2826617 Telephone: 053-5225922 Facsimile: E-mail: [email protected] 1